Earnings results expected in 38 days
Summary
DHR trading today lower at $203.98, a decrease of 0.48% from yesterday's close, completing a monthly decrease of -11.64% or $26.87. Over the past 12 months, DHR stock lost -14.8%.
DHR pays dividends to its shareholders, with the most recent payment made on Jan 31, 2025. The next announced payment will be in In 1 month on Apr 25, 2025 for a total of $0.32.
The last earnings report, released on Jan 29, 2025, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.67%, based on the last three reports. The next scheduled earnings report is due on Apr 21, 2025.
The stock of the company had never split.
The company's stock is traded on 12 different exchanges and in various currencies, with the primary listing on NYSE (USD).
Want to track DHR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
DHR Chart
Danaher Corp Dividends
 DHR In 3 months Estimated | Quarterly | $0.32 Per Share |
| DHR In 2 weeks Announced | Quarterly | $0.32 Per Share |
| DHR 2 months ago Paid | Quarterly | $0.27 Per Share |
| DHR 5 months ago Paid | Quarterly | $0.27 Per Share |
| DHR 8 months ago Paid | Quarterly | $0.27 Per Share |
| DHR 11 months ago Paid | Quarterly | $0.27 Per Share |
Danaher Corp Earnings
| 21 Apr 2025 (38 Days) Date | | - Cons. EPS | - EPS |
| 29 Jan 2025 Date | | 2.14 Cons. EPS | 2.14 EPS |
| 28 Jan 2025 Date | | 2.14 Cons. EPS | - EPS |
| 22 Oct 2024 Date | | 1.57 Cons. EPS | 1.71 EPS |
| 23 Jul 2024 Date | | 1.57 Cons. EPS | 1.72 EPS |
| DHR In 3 months Estimated | Quarterly | $0.32 Per Share |
| DHR In 2 weeks Announced | Quarterly | $0.32 Per Share |
| DHR 2 months ago Paid | Quarterly | $0.27 Per Share |
| DHR 5 months ago Paid | Quarterly | $0.27 Per Share |
| DHR 8 months ago Paid | Quarterly | $0.27 Per Share |
| DHR 11 months ago Paid | Quarterly | $0.27 Per Share |
| 21 Apr 2025 (38 Days) Date | | - Cons. EPS | - EPS |
| 29 Jan 2025 Date | | 2.14 Cons. EPS | 2.14 EPS |
| 28 Jan 2025 Date | | 2.14 Cons. EPS | - EPS |
| 22 Oct 2024 Date | | 1.57 Cons. EPS | 1.71 EPS |
| 23 Jul 2024 Date | | 1.57 Cons. EPS | 1.72 EPS |
Danaher Corp (DHR) FAQ
What is the stock price today?
The current price is $203.98.
On which exchange is it traded?
Danaher Corp is listed on NYSE.
What is its stock symbol?
The ticker symbol is DHR.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 176.57B.
What is the earnings per share?
The EPS is 0.
When is the next earnings date?
The next earnings report will release on Apr 21, 2025.
Has Danaher Corp ever had a stock split?
No, there has never been a stock split.
Danaher Corp Profile
| Diagnostics & Research Industry | Healthcare Sector | Mr. Steven M. Rales CEO | NYSE Exchange | US2358511028 ISIN |
| US Country | 61,000 Employees | 28 Mar 2025 Last Dividend | 2 Oct 2023 Last Split | 5 Jan 1979 IPO Date |
Overview
Danaher Corporation is a global powerhouse in the design, manufacturing, and marketing of a vast array of professional, medical, industrial, and commercial products and services. With its inception in 1969 and a significant rebranding in 1984, where it transitioned from Diversified Mortgage Investors, Inc. to Danaher Corporation, the company has established a formidable presence in various sectors. Headquartered in Washington, D.C., Danaher stands out through its commitment to innovation, excellence, and enhancing the quality of life worldwide.
Products and Services
- Biotechnology: Danaher's biotechnology segment is a provider of bioprocess technologies, consumables, and services enhancing the development and manufacture of therapeutics. This includes cell line and cell culture media development, chromatography resins, filtration technologies, aseptic fill-finish solutions, single-use hardware, and comprehensive services aimed at setting up full manufacturing suites.
- Life Sciences: This segment delivers a wide range of products including mass spectrometers, flow cytometry, genomics solutions, lab automation instruments, centrifugation, liquid handling automation instruments, antibodies and reagents, particle counting and characterization tools, microscopes, and protein consumables. Among the notable brands under the Life Sciences segment are ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX, each providing specialized products for genomic medicines and industrial filtration.
- Diagnostics: Danaher’s diagnostics sector offers a comprehensive range of chemistry, immunoassay, microbiology, automation systems, molecular diagnostics, acute care, and pathology diagnostics products. Aimed at hospitals, physicians' offices, reference laboratories, and other critical care settings, this segment ensures the delivery of clinical instruments, reagents, consumables, software, and dedicated services to support critical diagnostics.
Contact Information
Address: 2200 Pennsylvania Avenue, North West, Washington, DC, United States, 20037-1701
Phone: 202 828 0850
Website: https://www.danaher.com
2025 © Marketlog. All Rights Reserved.
